Drug Type Small molecule drug |
Synonyms 5-[3-(2-carboxy-4-oxo-4H-5-chromenyloxy)-2-hydroxypropoxy]-4-oxo-4H-2-chromenecarboxylic acid, Cromoglicate, Cromoglicate lisetil + [8] |
Target- |
Action inhibitors, stabilizers |
Mechanism Histamine release inhibitors, Mast cells stabilizers |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedPhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC33H38Cl2N2O12 |
InChIKeyVZZTWOVKCVPTSM-FJSYBICCSA-N |
CAS Registry110816-78-9 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Plaque psoriasis | Phase 2 | Germany | 01 Nov 2012 | |
Pruritus | Phase 2 | Germany | 01 Nov 2012 | |
Indolent systemic mastocytosis | Phase 2 | Germany | 01 Oct 2012 | |
Urticaria Pigmentosa | Phase 2 | Germany | 01 Oct 2012 | |
Asthma | Phase 2 | Japan | - | - |
Dermatitis, Atopic | Phase 2 | Japan | - | - |
Mastocytosis | Phase 2 | Germany | - | |
Psoriasis | Phase 2 | Germany | - | |
Psoriasis | Phase 2 | - | - | |
Psoriasis | Phase 2 | - | - |
Not Applicable | - | bgggbgmqfy(etkyqnfxhp) = koidzhdzxc dxkadpbmka (lyeunsvktx ) | - | 01 Oct 2018 | |||
bgggbgmqfy(etkyqnfxhp) = yujwsazwbi dxkadpbmka (lyeunsvktx ) |